Bris­tol My­er­s' CAR-T ther­a­py Breyanzi adds new ap­proval in man­tle cell lym­phoma

Bris­tol My­ers Squibb’s CAR-T ther­a­py Breyanzi scored its third ap­proval over the last sev­er­al months, this time in the third-line set­ting …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.